SGMO - Sangamo Therapeutics GAAP EPS of -$0.34 misses by $0.08 revenue of $2.04M misses by $6.07M March, 13 2024 10:02 AM Sangamo Therapeutics Inc. 2024-03-13 10:02:36 ET More on Sangamo Therapeutics Sangamo stock soars 37% on updates for Fabry disease therapy Seeking Alpha’s Quant Rating on Sangamo Therapeutics Historical earnings data for Sangamo Therapeutics Financial information for Sangamo Therapeutics For further details see: Sangamo Therapeutics GAAP EPS of -$0.34 misses by $0.08, revenue of $2.04M misses by $6.07M